http://rdf.ncbi.nlm.nih.gov/pubchem/reference/380612

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't
endingPage 7908
issn 1557-3265
1078-0432
issueIdentifier 23
pageRange 7900-7908
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 7900
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_aa00bc79015f2cdf9be69530d8a648d7
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e349ad837899f6e22986e62f961442e9
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dda75d066542b8a9cc629411008657f3
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2f2f58b4656d936311c1014b9af50e53
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_75daf4bcab4001d8b39ce3d3d6cc94db
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3fa4c21f0d19cca4a61e0af3cc396bd6
bibliographicCitation Molina JR, Kaufmann SH, Reid JM, Rubin SD, Gálvez-Peralta M, Friedman R, Flatten KS, Koch KM, Gilmer TM, Mullin RJ, Jewell RC, Felten SJ, Mandrekar S, Adjei AA, Erlichman C. Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data. Clin Cancer Res. 2008 Dec 01;14(23):7900–8. PMID: 19047120; PMCID: PMC2725396.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95d73f94f79c8f976d53034e4a92d30b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_52c99f5c3c42415c90901ac5f7754202
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dd274e36bd2149c0253cf9ff3d9e7ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e8d1f82b606cc170354453860161e88
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6765eda1b342d40bad62d34d7656eab7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f8e8bc209623d1cec03db8d46a74dc7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_117d3331ca9a439885e1bbc09e960fa0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2750f7b2e581e90444c2a85ba0ec7bbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fab090b0b5d44da408ca4b1d86276586
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c28205292dd3f421fab60ca211b79986
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd1c8eddd110bfd303b6e068b94354ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cedd75006a1fb5f51a07d11c3903106
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_948cec1d73a90ef22b96e607c6b0f09d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_80e91e6fd50e9c183b7aa379ef5dbc25
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2e14ad1a27c57de025e40bba78e2160
date 2008-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/19047120
https://doi.org/10.1158/1078-0432.ccr-08-0415
https://pubmed.ncbi.nlm.nih.gov/PMC2725396
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1557-3265
https://portal.issn.org/resource/ISSN/1078-0432
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
discusses http://id.nlm.nih.gov/mesh/M0029340
http://id.nlm.nih.gov/mesh/M0473129
http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D000971Q000493
http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011799Q000493
http://id.nlm.nih.gov/mesh/D023041
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D019772Q000493
http://id.nlm.nih.gov/mesh/D019772Q000009
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D019772Q000008
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D011799Q000009
http://id.nlm.nih.gov/mesh/D011799Q000008
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D000077341
http://id.nlm.nih.gov/mesh/D020714
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D066298
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.6.3.44
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1e4d7f806ea44eba476b32d2ebb4249
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127494626
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129347572

Total number of triples: 85.